Cardiometabolic Risk in Diabetes: Blood Pressure, Cholesterol, and Heart Outcomes

Evidence related to cardiometabolic risk

Evidence related to blood pressure, lipid profile, cardiovascular risk, cardiovascular events, and cardiometabolic risk markers in diabetes.

Crea tu Evidence Workspace

Guarda evidencia sobre los temas que te importan.

Studies

Evidence Pairs

Moderate Research Support

Relationship Confidence: 66/100

Evidence Intelligence™

Evidence Summary

A structured summary of where the evidence is strongest, mixed, or still emerging.

Executive Summary

Cardiometabolic Risk evidence appears to center on Exercise therapy.

Among 15 indexed studies and 5 interventions, the strongest signals are summarized from the available evidence. Metformin has been studied often, while Exercise therapy appears to have stronger current evidence signals.

Evidence is consistently positive across multiple studies.
Some evidence is positive, but results are not consistent across all studies.
Early findings are encouraging, but stronger trials are needed.

Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Key Finding

Evidence is consistently positive across multiple studies.

Interventions with strongest consistent evidence

Strongest consistent evidence

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

Exercise therapy appears to have a consistent beneficial signal in the indexed evidence.

View supporting studies

Evidence basis: 5 evidence pairs - 3 studies

Why this appears here

Moderate evidenceConsistent resultsPositive effect signalMultiple RCTs

Exercise therapy

3 studies

EvidenceScore™

69/100

ConsistencyScore™

67/100

Evidence Snapshot

Studies

Interventions

SGLT2 inhibitors → Systolic blood pressure

Across 2 studies, SGLT2 inhibitors shows a moderate positive signal for Systolic blood pressure.

2 studies

EvidenceScore™: 69/100

View supporting studies

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

Metformin is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

Metformin

SGLT2 inhibitors

Metformin

4 studies

EvidenceScore™

69/100

ConsistencyScore™

36/100

Why this appears here

Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results PresentNegative Results Present

Evidence basis: 22 evidence pairs - 15 studies

View supporting studies

Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Exercise therapy may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

Exercise therapy

Mediterranean diet

Exercise therapy

3 studies

EvidenceScore™

69/100

ConsistencyScore™

67/100

Why this appears here

Positive effect signalLimited study volume

Evidence basis: 13 evidence pairs - 9 studies

View supporting studies

Explore the Evidence

The sections below provide the complete evidence questions, supporting relationships, and underlying studies behind the summary above.

Preguntas respondidas por la evidencia

Does SGLT2 inhibitors improve systolic blood pressure?

intervention effectiveness

Moderate Evidence

SGLT2 inhibitors may improve Systolic blood pressure.

ConsistencyScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: Some evidence reported benefits while other evidence found little or no effect.

Ranked evidence signals

1
SGLT2 inhibitors
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Only a small number of supporting studies are available.
Population details are unavailable.

Does Exercise therapy improve systolic blood pressure?

intervention effectiveness

Moderate Evidence

Exercise therapy appears to improve Systolic blood pressure.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Exercise therapy
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 2 studies

Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.

Limitations

Only a small number of supporting studies are available.
Population details are unavailable.

Does Metformin improve triglycerides?

intervention effectiveness

Moderate Evidence

Metformin may worsen Triglycerides or be associated with harm.

ConsistencyScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: Some evidence reported worsening or harm while other evidence found little or no effect.

Ranked evidence signals

1
Metformin
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | weak negative | ConsistencyScore™ Mixed | 2 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Only a small number of supporting studies are available.
Population details are unavailable.

Does Mediterranean diet improve triglycerides?

intervention effectiveness

Moderate Evidence

Mediterranean diet may improve Triglycerides.

ConsistencyScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: Some evidence reported benefits while other evidence found little or no effect.

Ranked evidence signals

1
Mediterranean diet
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Only a small number of supporting studies are available.
Population details are unavailable.

Does SGLT2 inhibitors improve all-cause mortality?

intervention effectiveness

Moderate Evidence

SGLT2 inhibitors may improve All-cause mortality.

ConsistencyScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: Some evidence reported benefits while other evidence found little or no effect.

Ranked evidence signals

1
SGLT2 inhibitors
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Only a small number of supporting studies are available.
Population details are unavailable.

Does SGLT2 inhibitors improve diastolic blood pressure?

intervention effectiveness

Emerging Evidence

SGLT2 inhibitors appears to improve Diastolic blood pressure.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

1
SGLT2 inhibitors
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

Only one supporting study is available.
Consistency cannot yet be determined.
Population details are unavailable.

Does SGLT2 inhibitors improve total cholesterol?

intervention effectiveness

Emerging Evidence

SGLT2 inhibitors appears to improve Total cholesterol.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

1
SGLT2 inhibitors
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

Only one supporting study is available.
Consistency cannot yet be determined.
Population details are unavailable.

Does SGLT2 inhibitors improve hdl cholesterol?

intervention effectiveness

Emerging Evidence

Current evidence does not show a clear benefit of SGLT2 inhibitors for HDL cholesterol.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

1
SGLT2 inhibitors
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

Only one supporting study is available.
Consistency cannot yet be determined.
Population details are unavailable.

Evidence summary for AI and search

Evidence is consistently positive across multiple studies.
Some evidence is positive, but results are not consistent across all studies.
Early findings are encouraging, but stronger trials are needed.

Supporting Research

Selected studies that best represent the evidence behind this topic.

Exercise therapy reduces blood pressure in multimorbidity.

Highly relevant

Interventions:

Exercise therapy

Outcomes:

HDL cholesterol LDL cholesterol Systolic blood pressure Triglycerides

View research summary→

SGLT2 inhibitors improve atrial conduction time in diabetes

Representative

Interventions:

SGLT2 inhibitors

Outcomes:

Diastolic blood pressure Systolic blood pressure Total cholesterol Triglycerides

View research summary→

Early use of effective therapies may improve diabetes outcomes

Representative

Interventions:

Metformin

Outcomes:

HDL cholesterol LDL cholesterol Systolic blood pressure

View research summary→

Structured exercise improves weight loss after gastric bypass surgery

Representative

Interventions:

Exercise therapy Resistance training

Outcomes:

lipid profiles

View research summary→

Sitagliptin with Metformin Improves Metabolic Health

Representative

Interventions:

Metformin

Outcomes:

Total cholesterol Triglycerides

View research summary→

SGLT2 inhibitors reduce cardiovascular events in diabetes

Representative

Interventions:

SGLT2 inhibitors

Outcomes:

All-cause mortality Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)

View research summary→

Click any study to view the full research summary, or click interventions and outcomes to filter Evidence Explorer.

Evidence Tracker

Track Cardiometabolic Risk in Diabetes: Blood Pressure, Cholesterol, and Heart Outcomes evidence

Save this evidence topic and revisit it as new studies are added.